Allopregnanolone. Publications. Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial Neuroregenerative mechanisms of allopregnanolone in Alzheimer’s disease Allopregnanolone as regenerative therapeutic for Alzheimer's disease: Translational development and clinical promise Neurosteroids as regenerative agents in the brain: therapeutic implications Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease
